Wake Network, Inc. Receives Certificate of Drug Registration for Microdose Formulation in Jamaica Post published:September 23, 2021 Post category:Press Release
MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration Post published:September 23, 2021 Post category:Press Release
ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice Post published:September 23, 2021 Post category:Press Release
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers Post published:September 23, 2021 Post category:Press Release
Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data Post published:September 22, 2021 Post category:Press Release
Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders Post published:September 22, 2021 Post category:Press Release
Bright Minds Biosciences Provides Scientific Update Post published:September 22, 2021 Post category:Press Release
Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies Post published:September 21, 2021 Post category:Press Release
Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 Post published:September 21, 2021 Post category:Press Release
Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy Post published:September 21, 2021 Post category:Press Release